@ARTICLE{
author={Bar-Or Amit,Oh Jiwon,Dufek Michal,Budincevic Hrvoje,Habek Mario,Caunt Maresa,Thomas Piia,Sierzega Malgorzata,Clayton David,Cheng Ying Fang,Ratchford John,Goodyear Alexandra,Drulovic Jelena S},
year={2024},
title={Fenebrutinib maintains low disease activity in relapsing multiple sclerosis: results from the FENopta trial open-label extension},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={30},
number={3},
pages={1021-1022},
document_type={Meeting Abstract},
}